Wiley Paid $298 Million in 2021 for Hindawi's 200 Peer-Reviewed Journals and Has Since Retracted More Than 11,300 of Their Papers. By 2025 Hindawi Appeared in Wiley's Annual Report Only in the List of Subsidiaries.
In January 2021 Wiley announced that it had acquired Hindawi, an open-access publisher founded in Cairo in 1997 by Ahmed Hindawi and Nagwa Abdelmottaleb, for "a total purchase price of $298 million." The release described a privately held London company with more than 200 peer-reviewed journals, and projected revenue of approximately $40 million for the year ending 31 December 2020, up 50 percent on the year before. The business model was the usual one for open access: authors or their funders pay a fee, a journal sends the manuscript to reviewers, the reviewers say yes, and the article is published as a statement that someone qualified has read it.
Peer review runs on the assumption that the editor is the editor and the reviewer is the reviewer. Within three years of the sale, Wiley would be retracting papers by the thousand, closing journals and retiring the Hindawi name, and it would attribute a quarter's lost revenue on an earnings call to "the volume decline we experienced."
The Special Issues
The weak point was the special issue. Nature, in a December 2023 news report by Richard Van Noorden, described special issues as "collections of articles that are often overseen by guest editors and that have become notorious for being exploited by scammers to rapidly publish low-quality or sham papers." A guest editor could be invited, could invite reviewers, and could see the papers through. If the guest editor was the problem, so was every safeguard that depended on the guest editor.
In September 2022 Hindawi announced it would retract 511 articles across 16 journals. From mid-October 2022 to mid-January 2023 it stopped publishing special issues altogether, which Wiley's chief executive at the time, Brian Napack, called an "unplanned publishing pause." In April 2023 Wiley and Hindawi said that about 1,200 further articles had been identified. A Wiley spokesperson told Retraction Watch that "Special Issues in these journals were targeted by papermills and bad actors," and that researcher identities had been manipulated and content fabricated.
The Retractions
Nature reported in December 2023 that retractions for the year had passed 10,000, a record, and that more than 8,000 of them were Hindawi's. The notices cited factors such as "concerns that the peer review process has been compromised" and "systematic manipulation of the publication and peer-review process." A Hindawi whitepaper, summarised by Retraction Watch, set out the method. Outside vendors assessed each paper against a checklist of six indicators of manipulation, with at least two trained evaluators completing a questionnaire in a "bespoke software application". Papers over a threshold were retracted. Hindawi banned "several hundred" guest editors from future editorial roles and from publishing articles.
The counts differ by source and date. Retraction Watch had logged more than 3,400 Hindawi retractions in its own database by early December 2023 and said its entries were incomplete. In May 2024 a Wiley spokesperson told The Register that the publisher had "retracted more than 11,300 papers from its Hindawi portfolio" over the past two years. Retraction Watch wrote in March 2025 of "over 11,000 papers" retracted from former Hindawi journals. These are the same pile counted at different heights.
Nature's sleuths put the global total of recorded retractions at around 50,000 and called it only the tip of the iceberg. David Bimler, the New Zealand sleuth who works under the pseudonym Smut Clyde, told Nature that paper-mill products "are a problem even if no one reads them, because they get aggregated with others into review articles and laundered into the mainstream literature."
The Phrases
The sleuths had a method that did not require reading the science. Guillaume Cabanac of the University of Toulouse told Nature, as Mind Matters reported in August 2021, that his team had found "over 860 publications that included at least one tortured phrase," among them papers that used "counterfeit consciousness" where an author wanted to write "artificial intelligence." Thirty-one of those were in a single journal, Microprocessors and Microsystems. That finding concerned computer science journals generally and predates the Hindawi retractions.
The vocabulary has since been put to work by the publishers. Wiley's 2024 papermill detection service lists a tool called "Problematic phrase recognition," which flags "unusual alternatives to established terms." A company that bought a journal business for $298 million is piloting software to notice that the text was written by a thesaurus.
A different failure, from a different publisher, arrived in February 2024. Frontiers in Cell and Developmental Biology published an article containing an illustration of a rat, generated by Midjourney as the authors disclosed, with labels including "testtomcels." Frontiers said a reviewer had asked the authors to revise the figure and that they had not responded. The article was retracted on 16 February 2024 on the ground that it did not meet the journal's standards, so as "to protect the integrity of the scientific record." A reviewer told Motherboard that they had assessed the work on its scientific merit alone and that the decision to include the figure was left to Frontiers.
The Bill
Retraction Watch reported that the pause cost Hindawi about $9 million in lost revenue in the quarter ended 31 January 2023, and that Wiley's shares were down 16 percent from their opening level that day. On 6 December 2023 the interim chief executive, Matthew Kissner, told analysts: "This year, we project the revenue impact to be $35 million-$40 million." He put the EBITDA impact of Hindawi at $14 million. Kissner also announced that "now is the time to sunset the Hindawi brand and begin to fully integrate its 200 journals," with the transition due by the middle of 2024. Wiley said it had no plans to change author fees. Dorothy Bishop estimated that Hindawi had earned millions in article processing charges on retracted papers, and noted that the whitepaper left out the commercial incentives of publishers.
Four journals had been shut in May 2023 because paper mills had heavily affected them. In May 2024 Wiley discontinued 19 more. Its spokesperson said: "we reviewed our journal portfolio and decided to close 19 Hindawi journals that no longer serve their communities." The company presented the closures as part of integration, separate from paper mills. Clarivate had already removed 19 Hindawi journals from Web of Science in March 2023.
The Screening
In March 2024 Wiley announced a pilot of an AI-powered papermill detection service with Sage and IEEE, with six tools: papermill similarity detection, problematic phrase recognition, unusual publication behaviour detection, researcher identity verification, gen-AI generated content detection and a journal scope checker. Bob Howard of Sage said the industry needed "tools that allow reviewers and editors to focus on the content of the research" rather than on whether it was authentic. The release gave no price and no figure for how many honest submissions the tools would stop.
The other end of the pipe moves at its own pace. In April 2023 the sleuth Kevin Patrick sent Wiley's research integrity inbox a PubPeer thread about duplicated images in a paper from a former Hindawi journal. A Hindawi specialist replied that the concerns would be investigated. When Patrick asked for an update on 31 October 2024, the reply cited a high volume of emails. As of December 2024 the paper carried no notice of any kind. In March 2025 Retraction Watch counted 242 retractions so far that year in the International Wound Journal, a Wiley title, where one notice said the article "was accepted solely on the basis of a compromised peer review process" and a spokesperson said editors "anticipate additional retractions in the weeks to come." The investigation had come to the publisher's attention from a third party.
Wiley's annual report for the year to 30 April 2025 now carries a risk factor stating that research integrity "could adversely impact our open access publishing and article output by causing us to potentially pause publication, retract articles, or halt publication of a journal." Research revenue that year rose $32.8 million, or 3 percent, owing to author-funded open access, institutional models and AI licensing revenue, the last about $11 million. Open access article output grew by about 16 percent.
On 16 June 2026 Wiley reported full-year Research revenue of $1,130 million, up 5 percent, and said that submissions and output had risen significantly. The release does not mention Hindawi, integrity, retractions or paper mills.
Filed from public reporting:
- Wiley — "Wiley Announces the Acquisition of Hindawi"
- Nature — "More than 10,000 research papers were retracted in 2023 — a new record"
- Retraction Watch — "Hindawi reveals process for retracting more than 8,000 paper mill articles"
- Retraction Watch — "Wiley to stop using Hindawi name amid $18 million revenue decline"
- Retraction Watch — "Wiley paused Hindawi special issues amid quality problems, lost $9 million in revenue"
- Retraction Watch — "Wiley and Hindawi to retract 1,200 more papers for compromised peer review"
- MarketBeat — John Wiley & Sons Q2 2024 earnings call transcript
- The Register — Wiley closes 19 Hindawi journals
- Chemistry World — "Nineteen journals shut down by Wiley following delisting and paper mill problems"
- Mind Matters — "Science sleuths catch authors using AI tool for plagiarism" (quoting Nature)
- Popular Science — "A ridiculous AI-generated rat penis made it into a peer-reviewed journal"
- Wiley — "Wiley announces pilot of new AI-powered Papermill Detection service"
- Retraction Watch — "19 months and counting: Former Hindawi journal still hasn't marked paper"
- Retraction Watch — "Wiley journal retracts over 200 more papers"
- Wiley — Form 10-K for fiscal year ended 30 April 2025
- Wiley — "Research and AI Momentum, Record Margins, and Cash Flow Growth Highlight Wiley's Fourth Quarter and Fiscal 2026 Results"